Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (6) Blüthgen, Nils (1) Kammertöns, Thomas Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (3) Kobelt, Dennis Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (8) Rhein, Simone Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (5) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Leisegang, Matthias Dr. (2) (-) Biologie maligner Lymphome (6) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (1) (-) Molekulare Zellbiologie und Gentherapie (3) Proteom Dynamik (5) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) 2002 (1) 2003 (3) 2004 (2) 2005 (3) (-) 2006 (5) 2007 (2) (-) 2008 (3) 2009 (3) 2010 (5) 2011 (6) 2012 (5) 2013 (2) 2014 (2) 2015 (6) 2016 (3) 2017 (5) 2018 (2) 2019 (1) 2020 (5) 2021 (3) 2022 (5) 2023 (4) 8 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie Molekulare Zellbiologie und Gentherapie20062008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas 01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas 01. Mai 2008 / J Mol Med Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette M. Leisegang B. Engels P. Meyerhuber E. Kieback D. Sommermeyer S.A. Xue S. Reuss H. Stauss W. Uckert 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas
01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas
01. Mai 2008 / J Mol Med Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette M. Leisegang B. Engels P. Meyerhuber E. Kieback D. Sommermeyer S.A. Xue S. Reuss H. Stauss W. Uckert
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
